APPLICATION
ANDA065203
TYPE
ANDA
ORIGINAL APPROVAL
2004-07-15
LATEST ACTION
2006-02-13
ROUTE
TOPICAL
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
NYSTATINPrescription
NYSTATIN 100,000 UNITS/GM · POWDER · TOPICAL
Approval history
2006-02-13Labeling · Supplement 4AP
2004-07-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.